Sort by
Refine Your Search
-
(SAiGENCI). The Zhang lab is well-supported, with funding from a substantial start-up package as well as external grants from the Australian Research Council (ARC) and the Australian National Health and
-
an employer contribution of 17% superannuation. 30 Months Fixed term Full time position. The University of Adelaide is seeking a research fellow to support the ongoing research activities in the area of
-
to develop their research expertise relevant to their particular field of research. This position is funded by the ASIC Defence Trailblazer Grant. To be successful you will need: A PhD in Mathematics, Computer
-
computer vision and machine learning research group in Australia -- and contribute to world-leading research projects at the CommBank Centre for Foundational AI This postdoctoral research position is part of
-
the direction of A/Prof Claudia Szabo in the School of Computer and Mathematical Sciences at the University of Adelaide. This position will work with our partners Praetorian Aeronautics and their testing team
-
holds Bachelors’ degrees in English literature (with Honours) (1961), and musicology (with Honours) (1970) from The University of Adelaide, and a PhD from the same university (1979). Her work includes the
-
with hands-on implementation and testing, working closely with both academia and industry through partnerships such as the Silanna Group, the BECA Group and REQUIEM Systems. As part of the dynamic and
-
contribution of 17% superannuation applies. Fulltime, fixed term research position, available for 12 months. Research Fellow Opportunity in Protein Biochemistry. This is an exciting opportunity for a completed
-
Centre for Epigenetics (ACE), the South Australian immunoGENomics Cancer Institute (SAiGENCI) is inviting applications for a Level A Researcher in the field of cancer development and stem cells. SAiGENCI
-
Technology and Therapeutics Laboratory is an exciting, collaborative, and innovative research group working at the forefront of CRISPR technology, genetic disease therapeutics, mammalian gene drive